Device Trial Radar · NCT03512301
CAMCI: Advancing the Use of Computerized Screening in Healthcare
Last checked: Nov 20, 2026Latest source record: Jun 26, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
773
Actual
Start
Aug 8, 2019
Primary completion
May 31, 2023
Study completion May 31, 2023
Sponsor
- Lead sponsor
- Psychology Software Tools, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- National Institute on Aging (NIA)
- First posted
- Apr 30, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Screening
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 60 years, up to 95 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Cognitive impairment is a significant health problem in the United States, resulting in costs over $100 billion a year. We will provide an efficient, effective, and financially intelligent solution to Primary Care Physician's to identify cognitive impairment in the earliest stages, delay progression through appropriate treatment, and to afford patients the opportunity to make future plans at a time when symptoms are mild and patients are able to make informed decisions concerning financial and life activities. This has the potential to delay devastating effects of cognitive impairment, and to lessen the financial burden on the health care system in the United States.
Conditions
- Cognitive Dysfunction
- Cognitive Impairment
- Cognitive Decline
- Cognitive Change
Interventions
CAMCIDevice
CAMCI is a computerized screening tool for the assessment of cognitive status. CAMCI accurately assesses cognitive performance using standard neuropsychological tests of memory, attention, and executive ability modified for computer administration, and an innovative Virtual Environment task, testing domains such as incidental memory, not easily assessed using paper-pencil tests. Computer-administered tasks ensure standard administration and scoring, avoiding inter-site and inter-examiner variability. The CAMCI battery consists of tasks testing multiple aspects of cognitive function, and a series of self-report questions administered via tablet computer. Using touchscreen technology for response input, CAMCI takes approximately 15-20 minutes to complete.
MoCADiagnostic test
The Montreal Cognitive Assessment (MoCA) is a rapid screening tool used to detect mild cognitive impairment (MCI), assessing cognitive domains (visuospatial skills, executive function, memory, attention, language, and orientation). Individual test scores are summed into a total score from 0 (worst) to 30 (best). Individuals may achieve any score within that range. Individual test scores are not reported. Scores: 26-30 considered Normal; 19-25 may suggest Mild Cognitive Impairment (MCI); 10-18 can suggest moderate impairment; \< 10 may indicate severe impairment
Clinical AdjudicationDiagnostic test
Cognitive status assessed by traditional neuropsychological tests measuring visuospatial skills, executive function, memory, attention, language, orientation. Results compared to age-adjusted norms, reviewed by expert neuropsychologists for consensus classification, per Univ of Pittsburgh Alzheimers Disease Research Ctr and Ntl Alzheimers Coordinating Ctr, and Alzheimer's Assoc criteria. Final classification adjusted per clinical judgment. Impaired: ≥3 scores ≥2SD below norms Indeterminate: ≤2 scores \>1SD below norms Normal: Neither criteria met. Total and domain scores not reported.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Agreement Analysis (Agreement to Reference Standard) - Test GroupTime frame: baseline
- Agreement Analysis (Agreement to Non-Reference Standard) - Test GroupTime frame: baseline
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Indiana University
Indianapolis, Indiana
Psychology Software Tools
Sharpsburg, Pennsylvania
Baylor College of Medicine
Houston, Texas
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.